AzTrials
AzTrials

ContraceptionNCT05252052

Contraception Perspectives in Adolescents in Haiti

An observational study of Contraception, run by Children's Mercy Hospital Kansas City at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall goal of this study is to assess facilitators and barriers to contraception with a focus on long-acting reversible contraception (LARC) among adolescents and health care providers (HCPs) in rural Haiti. The investigator plans to accomplish the following objectives: Read more about this study

Who is it for?
Ages 14 to 24 years, women onlyHealthy volunteers can take part
Conditions the study is for
Contraception
What is being tested?
Interviews/Surveys
How many people
200 participants
Where
1 siteUnited States
Study dates
22 Mar 2021to 31 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 24 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Study population: Adolescents 14-24 years old and health care providers in rural Haiti

Who may be able to join

  • Adolescents who are biologically female and have reproductive potential (14-24 years old)
  • Adolescents who reside in the birthing clinic catchment area
  • Health care providers, including nurse midwives, who work at the local birthing clinic and providers at the local hospital

Who cannot join

  • -Subjects who are determined to have severe psychiatric illness or cognitive impairment (based on research team assessment).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Mercy Hospital

    Kansas City, Missouri, 64108

Other trials in United States

About this study

Official title: Barriers and Facilitators to Long-Acting Reversible Contraception: Perspectives of Adolescents and Healthcare Providers in Rural Haiti

The overall goal of this study is to assess facilitators and barriers to contraception with a focus on long-acting reversible contraception (LARC) among adolescents and health care providers (HCPs) in rural Haiti. The investigator plans to accomplish the following objectives:

Read the detailed description

Objective 1: Develop locally-informed surveys and in-depth interview guides, based on the ecologically-expanded Theory of Planned Behavior, to assess attitudes, social norms, perceived behavioral control, and intentions regarding contraception, with a focus on LARC, among adolescents and HCPs in rural Haiti.

Objective 2: Conduct a formative mixed methods study of attitudes, social norms, perceived behavioral control, and intentions regarding contraception, with a focus on LARC, among female adolescents (N=150 survey, 25-50 in-depth interviews) and HCPs (N=15; survey and in-depth interviews) in rural Haiti.

Conditions
Contraception
Being tested
Interviews/Surveys

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interviews/SurveysOther

    This is a cross sectional survey and interviews of adolescents 14- 18 years old and HCPs living in rural Haiti

Study groups in NCT05252052
Study groupRoleWhat they receive
Adolescents 14-24 years oldAdolescents 14-24 years old
Receives: Other: Interviews/Surveys
Health care providers in rural HaitiHealth care providers in rural Haiti
Receives: Other: Interviews/Surveys

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identification of facilitators and barriers to contraception use

    The primary outcome is identification of facilitators and barriers to contraception use among adolescent participants based on responses to the eTPB domains described in Table 1. The investigator will also explore facilitators and barriers to contraception use among HCP participants.

    Measured: Data collection will occur over one day for individual participants. Study data collection will occur over 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2022
  2. Study start22 Mar 2021
  3. Primary completion31 Mar 2023
  4. Study completion31 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05252052
Sponsor's protocol ID
STUDY00001626
Status last verified
Jul 2023
First submitted
7 Jan 2022
Last updated
2 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Rupe ER, Rodean J, Hurley EA, Miller MK, Boncoeur MD, Masonbrink AR. Menstrual health among adolescents and young adults in rural Haiti. Reprod Health. 2022 Dec 20;19(1):227. doi: 10.1186/s12978-022-01533-4.

    PubMed 36539795
  • Masonbrink AR, Hurley EA, Schuetz N, Rodean J, Rupe E, Lewis K, Boncoeur MD, Miller MK. Sexual behaviors, contraception use and barriers among adolescents and young adults in rural Haiti. BMC Womens Health. 2023 Mar 27;23(1):137. doi: 10.1186/s12905-023-02268-5.

    PubMed 36973773

Questions about this trial

What is this clinical trial studying?

An observational study of Contraception, run by Children's Mercy Hospital Kansas City at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identification of facilitators and barriers to contraception use (time frame: Data collection will occur over one day for individual participants. Study data collection will occur over 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05252052, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in